Status Epilepticus—Work-Up and Management in Children

Abstract Status epilepticus (SE) is one of the most common neurological emergencies in children and has a mortality of 2 to 4%. Admissions for SE are very resource-consuming, especially in refractory and super-refractory SE. An increasing understanding of the pathophysiology of SE leaves room for improving SE treatment protocols, including medication choice and timing. Selecting the most efficacious medications and giving them in a timely manner may improve outcomes. Benzodiazepines are commonly used as first line and they can be used in the prehospital setting, where most SE episodes begin. The diagnostic work-up should start simultaneously to initial treatment, or as soon as possible, to detect potentially treatable causes of SE. Although most etiologies are recognized after the first evaluation, the detection of more unusual causes may become challenging in selected cases. SE is a life-threatening medical emergency in which prompt and efficacious treatment may improve outcomes. We provide a summary of existing evidence to guide clinical decisions regarding the work-up and treatment of SE in pediatric patients.

[1]  Nathan Fountain,et al.  Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. , 2019, The New England journal of medicine.

[2]  J. Wheless,et al.  Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters—a randomized, double‐blind, placebo‐controlled trial , 2019, Epilepsia.

[3]  M. Walker,et al.  Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time: A Systematic Review and Meta-analysis. , 2019, JAMA neurology.

[4]  T. Loddenkemper,et al.  Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus , 2019, Neurology.

[5]  C. Gamble,et al.  Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial , 2019, The Lancet.

[6]  F. Babl,et al.  Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial , 2019, The Lancet.

[7]  F. Rosenow,et al.  Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population‐based study on German health insurance data , 2019, Epilepsia.

[8]  N. Gaspard,et al.  New onset refractory status epilepticus (NORSE) , 2019, Seizure.

[9]  M. Wainwright,et al.  Novel drugs and early polypharmacotherapy in status epilepticus , 2019, Seizure.

[10]  A. Rotenberg,et al.  Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus , 2019, Seizure.

[11]  W. Tatum,et al.  Pediatric refractory and super-refractory status epilepticus , 2019, Seizure.

[12]  Anup D. Patel,et al.  A hospital-based study on caregiver preferences on acute seizure rescue medications in pediatric patients with epilepsy: Intranasal midazolam versus rectal diazepam , 2019, Epilepsy & Behavior.

[13]  W. Gaillard,et al.  Timing and selection of first antiseizure medication in patients with pediatric status epilepticus , 2019, Epilepsy Research.

[14]  J. Kapur Role of NMDA receptors in the pathophysiology and treatment of status epilepticus , 2018, Epilepsia open.

[15]  T. Loddenkemper,et al.  Estimating the cost of admissions related to convulsive status epilepticus in the United States of America , 2018, Seizure.

[16]  H. Goodkin,et al.  Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. , 2018, Pediatric neurology.

[17]  T. Loddenkemper,et al.  Long‐term outcomes of status epilepticus: A critical assessment , 2018, Epilepsia.

[18]  H. Goodkin,et al.  Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus , 2018, Epilepsy Research.

[19]  S. Sinha,et al.  Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures , 2018, Annals of neurology.

[20]  K. Kapur,et al.  Factors associated with treatment delays in pediatric refractory convulsive status epilepticus , 2018, Neurology.

[21]  K. Kapur,et al.  Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus , 2018, JAMA neurology.

[22]  L. Lagae,et al.  Proposed consensus definitions for new‐onset refractory status epilepticus (NORSE), febrile infection‐related epilepsy syndrome (FIRES), and related conditions , 2018, Epilepsia.

[23]  L. Ladino,et al.  Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review , 2018, Seizure.

[24]  Anup D. Patel,et al.  Healthcare Utilization Characteristics for Intranasal Midazolam Versus Rectal Diazepam , 2018, Journal of child neurology.

[25]  C. Gillberg,et al.  Long‐term behavioural outcomes after paediatric convulsive status epilepticus: a population‐based cohort study , 2017, Developmental medicine and child neurology.

[26]  C. Gillberg,et al.  Long-term prognosis after childhood convulsive status epilepticus: a prospective cohort study. , 2017, The Lancet. Child & adolescent health.

[27]  J. Kalita,et al.  Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study , 2017, Epilepsy & Behavior.

[28]  K. Kapur,et al.  Rescue Medications in Epilepsy Patients: A Family Perspective , 2017, Seizure.

[29]  Colin A. Ellis,et al.  Timing is everything: Where status epilepticus treatment fails , 2017, Annals of neurology.

[30]  A. Al-Asmi,et al.  Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study , 2017, Seizure.

[31]  T. Loddenkemper,et al.  Nonintravenous rescue medications for pediatric status epilepticus: A cost‐effectiveness analysis , 2017, Epilepsia.

[32]  M. Rogawski,et al.  First‐in‐man allopregnanolone use in super‐refractory status epilepticus , 2017, Annals of clinical and translational neurology.

[33]  Anup D. Patel,et al.  Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals , 2017, Journal of child neurology.

[34]  Anup D. Patel,et al.  Reduced Emergency Department Utilization by Patients With Epilepsy Using QI Methodology , 2017, Pediatrics.

[35]  Tobias Loddenkemper,et al.  Refractory status epilepticus in children with and without prior epilepsy or status epilepticus , 2017, Neurology.

[36]  É. Azoulay,et al.  Hypothermia for Neuroprotection in Convulsive Status Epilepticus. , 2016, The New England journal of medicine.

[37]  Yingying Su,et al.  Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China , 2016, CNS Drugs.

[38]  C. Avolio,et al.  Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population , 2016, Seizure.

[39]  M Brandon Westover,et al.  Therapeutic coma for status epilepticus , 2016, Neurology.

[40]  K. Kapur,et al.  Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital* , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[41]  Y. Ng,et al.  Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study. , 2016, Pediatric neurology.

[42]  J. Wheless,et al.  Burden of Seizure Clusters on Patients with Epilepsy and Caregivers (P6.343) , 2016 .

[43]  J. F. Kerrigan,et al.  Ketogenic diet treatment for pediatric super-refractory status epilepticus , 2016, Seizure.

[44]  Ziyu Zhao,et al.  A Comparison of Midazolam, Lorazepam, and Diazepam for the Treatment of Status Epilepticus in Children , 2016, Journal of child neurology.

[45]  A. Rossetti,et al.  Monotherapy or Polytherapy for First-Line Treatment of SE? , 2016, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[46]  M. Baulac,et al.  Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial , 2016, The Lancet Neurology.

[47]  D. Treiman,et al.  Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society , 2016, Epilepsy currents.

[48]  Y. Lee,et al.  Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures , 2016, Korean journal of pediatrics.

[49]  S. Marsch,et al.  Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study , 2016, CNS Drugs.

[50]  P. Horn,et al.  Efficacy of nonvenous medications for acute convulsive seizures , 2015, Neurology.

[51]  V. Sabharwal,et al.  Propofol–ketamine combination therapy for effective control of super-refractory status epilepticus , 2015, Epilepsy & Behavior.

[52]  Simon Shorvon,et al.  A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus , 2015, Epilepsia.

[53]  W. Löscher Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models , 2015, Epilepsy & Behavior.

[54]  P. Satishchandra,et al.  Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot study , 2015, Epilepsy Research.

[55]  C. Gurses,et al.  Intravenous levetiracetam treatment in status epilepticus: A prospective study , 2015, Epilepsy Research.

[56]  Tobias Loddenkemper,et al.  Time from convulsive status epilepticus onset to anticonvulsant administration in children , 2015, Neurology.

[57]  A. Bhalla,et al.  Levetiracetam versus phenytoin in management of status epilepticus , 2015, Journal of Clinical Neuroscience.

[58]  T. Loddenkemper,et al.  Pediatric status epilepticus management , 2014, Current opinion in pediatrics.

[59]  W. Gaillard,et al.  Pediatric status epilepticus: identification and evaluation , 2014, Current opinion in pediatrics.

[60]  M. Rogawski,et al.  Pediatric super‐refractory status epilepticus treated with allopregnanolone , 2014, Annals of neurology.

[61]  R. Tasker,et al.  Intensive Care Treatment of Uncontrolled Status Epilepticus in Children: Systematic Literature Search of Midazolam and Anesthetic Therapies* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[62]  R. Griggs,et al.  The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease , 2014, Neurology.

[63]  J. Chamberlain,et al.  Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. , 2014, JAMA.

[64]  Shumei S. Sun,et al.  Emergency management of febrile status epilepticus: Results of the FEBSTAT study , 2014, Epilepsia.

[65]  S. Shorvon,et al.  The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies , 2014, Seizure.

[66]  F. Rincon,et al.  The Epidemiology of Status Epilepticus in the United States , 2014, Neurocritical Care.

[67]  R. Berg,et al.  Electrographic status epilepticus and long-term outcome in critically ill children , 2014, Neurology.

[68]  Shumei S. Sun,et al.  Hippocampal sclerosis after febrile status epilepticus: The FEBSTAT study , 2014, Annals of neurology.

[69]  I. Valencia,et al.  Efficacy of Lacosamide as Adjunctive Therapy in Children With Refractory Epilepsy , 2014, Journal of child neurology.

[70]  D. Goldstein,et al.  Gaps and opportunities in refractory status epilepticus research in children: A multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG) , 2013, Seizure.

[71]  C. Clark,et al.  Hippocampal volume loss following childhood convulsive status epilepticus is not limited to prolonged febrile seizures , 2013, Epilepsia.

[72]  J. Szaflarski,et al.  Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study , 2013, Epilepsia.

[73]  K. Sawanyawisuth,et al.  The efficacy of intravenous sodium valproate and phenytoin as the first-line treatment in status epilepticus: a comparison study , 2013, BMC Neurology.

[74]  D. Naylor,et al.  Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus , 2013, Neurobiology of Disease.

[75]  Mohammad Reza Najafi,et al.  A Comparative Assessment the Efficacy of Intravenous Infusion of Sodium Valproate and Phenytion in the Treatment of Status Epilepticus , 2013, International journal of preventive medicine.

[76]  R. Tasker,et al.  Pediatric intensive care treatment of uncontrolled status epilepticus. , 2013, Critical care clinics.

[77]  M. Falip,et al.  Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: A multicentric prospective study , 2013, Seizure.

[78]  M. Sperling,et al.  Treatment of Status Epilepticus: An International Survey of Experts , 2013, Neurocritical Care.

[79]  N. Khosroshahi,et al.  Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[80]  S. Shorvon,et al.  The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. , 2012, Brain : a journal of neurology.

[81]  J. Kapur,et al.  O Brother, Wherefore Are Thou? Calcium-Permeable AMPA Receptors Make an Appearance in Adult Status Epilepticus , 2013, Epilepsy currents.

[82]  M. Mastrangelo,et al.  Diagnostic work-up and therapeutic options in management of pediatric status epilepticus , 2012, World Journal of Pediatrics.

[83]  Paul M. Vespa,et al.  Guidelines for the Evaluation and Management of Status Epilepticus , 2012, Neurocritical Care.

[84]  R. Conwit,et al.  Intramuscular versus intravenous therapy for prehospital status epilepticus. , 2012, New England Journal of Medicine.

[85]  Andrea O Rossetti,et al.  Management of refractory status epilepticus in adults: still more questions than answers , 2011, The Lancet Neurology.

[86]  R. Scott,et al.  Death within 8 years after childhood convulsive status epilepticus: a population-based study. , 2011, Brain : a journal of neurology.

[87]  Simon Shorvon,et al.  The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. , 2011, Brain : a journal of neurology.

[88]  H. Goodkin,et al.  Treatment of Pediatric Status Epilepticus , 2011, Current treatment options in neurology.

[89]  B. Burnand,et al.  Second‐line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam , 2011, Epilepsia.

[90]  E. Hilmas,et al.  Levetiracetam for the treatment of pediatric status epilepticus: A case series , 2011, Journal of Pediatric Neurology.

[91]  J. S. Leeder,et al.  Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study , 2011, Clinical pharmacology and therapeutics.

[92]  C. Kellinghaus,et al.  Intravenous lacosamide for treatment of status epilepticus , 2011, Acta neurologica Scandinavica.

[93]  J. Miró,et al.  Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: A multicentric observational study , 2011, Seizure.

[94]  A. McGonigal,et al.  Generalized convulsive status epilepticus management in adults: A cohort study with evaluation of professional practice , 2010, Epilepsia.

[95]  Terrie Inder,et al.  Neonatal status epilepticus. , 2010, Seminars in pediatric neurology.

[96]  M. Manfredi,et al.  Intravenous Levetiracetam as first‐line treatment of status epilepticus in the elderly , 2010, Acta neurologica Scandinavica.

[97]  S. Krishnamurthy,et al.  Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. , 2010, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[98]  N. Watemberg,et al.  A Suggested Approach to the Etiologic Evaluation of Status Epilepticus in Children: What to Seek After the Usual Causes Have Been Ruled Out , 2010, Journal of child neurology.

[99]  D. Naylor,et al.  Molecular basis of self‐sustaining seizures and pharmacoresistance during status epilepticus: The receptor trafficking hypothesis revisited , 2009, Epilepsia.

[100]  J. Pascual,et al.  Experience with Intravenous Levetiracetam in Status Epilepticus , 2009, CNS drugs.

[101]  K. Sawanyawisuth,et al.  Predictors and prognosis of status epilepticus treated with intravenous sodium valproate. , 2009, Epileptic disorders : international epilepsy journal with videotape.

[102]  M. Müller,et al.  Two years of experience in the treatment of status epilepticus with intravenous levetiracetam , 2009, Epilepsy & Behavior.

[103]  C. Kellinghaus,et al.  Intravenous levetiracetam as treatment for status epilepticus , 2009, Journal of Neurology.

[104]  R. Scott,et al.  Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study , 2008, The Lancet Neurology.

[105]  W. Oertel,et al.  Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[106]  R. Chandra,et al.  Randomized study of intravenous valproate and phenytoin in status epilepticus , 2007, Seizure.

[107]  L. Gjerstad,et al.  Valproate is an effective, well‐tolerated drug for treatment of status epilepticus/serial attacks in adults , 2007, Acta neurologica Scandinavica. Supplementum.

[108]  A. Rossetti Sodium valproate vs phenytoin in status epilepticus: A pilot study , 2007, Neurology.

[109]  S. Ashwal,et al.  Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review) , 2006, Neurology.

[110]  R. Scott,et al.  Outcome of paediatric convulsive status epilepticus: a systematic review , 2006, The Lancet Neurology.

[111]  J. Kalita,et al.  Sodium valproate vs phenytoin in status epilepticus: A pilot study , 2006, Neurology.

[112]  Rod C Scott,et al.  Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study , 2006, The Lancet.

[113]  Y. Nakajima,et al.  A Prospective, Randomized Study , 2006 .

[114]  A. Auvinen,et al.  Treatment delay and the risk of prolonged status epilepticus , 2005, Neurology.

[115]  D. Naylor,et al.  Trafficking of GABAA Receptors, Loss of Inhibition, and a Mechanism for Pharmacoresistance in Status Epilepticus , 2005, The Journal of Neuroscience.

[116]  H. Goodkin,et al.  Status Epilepticus Increases the Intracellular Accumulation of GABAA Receptors , 2005, The Journal of Neuroscience.

[117]  S. van Gestel,et al.  Propofol and thiopental for refractory status epilepticus in children , 2005, Neurology.

[118]  J. Perlin,et al.  Estimating the economic burden of status epilepticus to the health care system , 2005, Seizure.

[119]  A. Marmarou,et al.  Time to treatment in prolonged seizure episodes , 2004, Epilepsy & Behavior.

[120]  K. Yu,et al.  Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures , 2003, Epilepsia.

[121]  R. Koul,et al.  Eight-Year Study of Childhood Status Epilepticus: Midazolam Infusion in Management and Outcome , 2002, Journal of child neurology.

[122]  Stephen Maren,et al.  Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus , 2002, Epilepsy Research.

[123]  P. Garcia,et al.  Incidence and mortality of generalized convulsive status epilepticus in California , 2002, Neurology.

[124]  W. Hauser,et al.  Long-term mortality after a first episode of status epilepticus , 2002, Neurology.

[125]  Jan Claassen,et al.  Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review , 2002, Epilepsia.

[126]  M R Segal,et al.  A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. , 2001, The New England journal of medicine.

[127]  D. Gilbert Practice parameter: Evaluating a first nonfebrile seizure in children: Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society , 2001, Neurology.

[128]  S. Moss,et al.  Constitutive Endocytosis of GABAA Receptors by an Association with the Adaptin AP2 Complex Modulates Inhibitory Synaptic Currents in Hippocampal Neurons , 2000, The Journal of Neuroscience.

[129]  P Jallon,et al.  Incidence of status epilepticus in French-speaking Switzerland , 2000, Neurology.

[130]  S. Ashwal,et al.  Practice parameter: Evaluating a first nonfebrile seizure in children , 2000, Neurology.

[131]  W. Rosenfeld,et al.  Treating repetitive seizures with a rectal diazepam formulation , 1998, Neurology.

[132]  B. Uthman,et al.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. , 1998, The New England journal of medicine.

[133]  R. Kuzniecky,et al.  A comparison of rectal diazepam gel and placebo for acute repetitive seizures. , 1998, The New England journal of medicine.

[134]  R. Macdonald,et al.  Rapid Seizure-Induced Reduction of Benzodiazepine and Zn2+ Sensitivity of Hippocampal Dentate Granule Cell GABAA Receptors , 1997, The Journal of Neuroscience.

[135]  John Keith Brown,et al.  NASAL RATHER THAN RECTAL BENZODIAZEPINES IN THE MANAGEMENT OF ACUTE CHILDHOOD SEIZURES? , 1996, Developmental medicine and child neurology.

[136]  W. Hauser,et al.  A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia , 1996, Neurology.

[137]  J. Golding,et al.  Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. , 1993, BMJ.

[138]  S. Moshé,et al.  Low morbidity and mortality of status epilepticus in children. , 1989, Pediatrics.

[139]  D. Treiman,et al.  Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam , 1988, Experimental Neurology.

[140]  K. Rawal,et al.  Status epilepticus. , 1985, Critical care clinics.

[141]  Corsellis Ja,et al.  Neuropathology of status epilepticus in humans. , 1983, Advances in neurology.

[142]  C. Bruton,et al.  Neuropathology of status epilepticus in humans. , 1983, Advances in neurology.

[143]  M. Aminoff,et al.  Status epilepticus: Causes, clinical features and consequences in 98 patients , 1980 .

[144]  B. Meldrum,et al.  Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. , 1973, Archives of neurology.

[145]  B. Meldrum,et al.  Physiology of status epilepticus in primates. , 1973, Archives of neurology.

[146]  B. Meldrum,et al.  Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. , 1973, Archives of neurology.

[147]  R. Norman The Neuropathology of Status Epilepticus , 1964, Medicine, science, and the law.